Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

759 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis.
Kato H, Tsujii H, Miyamoto T, Mizoe JE, Kamada T, Tsuji H, Yamada S, Kandatsu S, Yoshikawa K, Obata T, Ezawa H, Morita S, Tomizawa M, Morimoto N, Fujita J, Ohto M; Liver Cancer Working Group. Kato H, et al. Among authors: morimoto n. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1468-76. doi: 10.1016/j.ijrobp.2004.01.032. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275734 Clinical Trial.
Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma.
Ogasawara S, Kanai F, Obi S, Sato S, Yamaguchi T, Azemoto R, Mizumoto H, Koushima Y, Morimoto N, Hirata N, Toriyabe T, Shinozaki Y, Ooka Y, Mikata R, Chiba T, Okabe S, Imazeki F, Yoshikawa M, Yokosuka O. Ogasawara S, et al. Among authors: morimoto n. Hepatol Int. 2011 Sep;5(3):850-6. doi: 10.1007/s12072-010-9249-4. Epub 2011 Jan 22. Hepatol Int. 2011. PMID: 21484134
Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents.
Seko Y, Moriguchi M, Takahashi A, Yamaguchi K, Umemura A, Okuda K, Kataoka S, Unozawa H, Kobayashi K, Ogasawara S, Sato R, Tsuchiya S, Watanabe S, Morimoto N, Iwai K, Aramaki T, Kato N, Itoh Y. Seko Y, et al. Among authors: morimoto n. J Gastroenterol. 2022 Feb;57(2):90-98. doi: 10.1007/s00535-021-01837-5. Epub 2022 Jan 15. J Gastroenterol. 2022. PMID: 35031857
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study.
Kobayashi K, Ogasawara S, Maruta S, Okubo T, Itokawa N, Haga Y, Seko Y, Moriguchi M, Watanabe S, Shiko Y, Takatsuka H, Kanzaki H, Koroki K, Inoue M, Nakamura M, Kiyono S, Kanogawa N, Kondo T, Suzuki E, Ooka Y, Nakamoto S, Inaba Y, Ikeda M, Okabe S, Morimoto N, Itoh Y, Nakamura K, Ito K, Azemoto R, Atsukawa M, Itobayashi E, Kato N. Kobayashi K, et al. Among authors: morimoto n. Clin Cancer Res. 2023 Dec 1;29(23):4760-4769. doi: 10.1158/1078-0432.CCR-23-1462. Clin Cancer Res. 2023. PMID: 37796614
The successful treatment of hepatocellular carcinoma arising from congenital hepatic fibrosis using radiofrequency ablation under laparoscopy.
Hirosawa T, Morimoto N, Miura K, Ono K, Watanabe S, Fujieda T, Murayama K, Takaoka Y, Nomoto H, Tsukui M, Isoda N, Niki T, Tokushige K, Yamamoto H. Hirosawa T, et al. Among authors: morimoto n. Clin J Gastroenterol. 2019 Jun;12(3):223-230. doi: 10.1007/s12328-018-00932-0. Epub 2019 Jan 7. Clin J Gastroenterol. 2019. PMID: 30617852
A successful treatment for hepatocellular carcinoma with Osler-Rendu-Weber disease using radiofrequency ablation under laparoscopy.
Takaoka Y, Morimoto N, Miura K, Nomoto H, Murayama K, Hirosawa T, Watanabe S, Fujieda T, Ttsukui M, Kawata H, Niki T, Isoda N, Iijima M, Yamamoto H. Takaoka Y, et al. Among authors: morimoto n. Clin J Gastroenterol. 2018 Dec;11(6):501-506. doi: 10.1007/s12328-018-0877-x. Epub 2018 Jun 16. Clin J Gastroenterol. 2018. PMID: 29909559
759 results